In order to bring you the best possible user experience, this site uses Javascript. If you are seeing this message, it is likely that the Javascript option in your browser is disabled. For optimal viewing of this site, please ensure that Javascript is enabled for your browser.
Did you know that your browser is out of date? To get the best experience using our website we recommend that you upgrade to a newer version. Learn more.

A 53-year-old woman worried about risk of myocardial infarction

By Christi Deaton and Maria Antonopoulou, Primary Care and Risk Factor Management Section

Risk Factors and Prevention


The case

A 53-year-old woman visits her general practitioner because she is worried about her risk of having a myocardial infarction (MI). Her father died at age 65 following an ST-Elevation Myocardial Infarction (STEMI) and began having angina in his 50s. She began smoking in her late teens as her parents smoked. She currently smokes one pack per day. She has no siblings and no current medications.

She has a BMI of 30, and she has a waist circumference of 90 cm. She recently started walking every weekend with friends for 1 hour. Her BP is 143/87 and HR 76 and regular.

Her blood tests show the following results:

  • TCHOL: 298mg/dL (7.7 mmol/L)
  • LDL: 212 mg/dL (5.4 mmol/L
  • HDL: 45 mg/dL (1.16 mmol/L)
  • HbA1C: 5.1%

Test your knowledge

 

Interested in risk assessment tools?

You can use the ESC CVD Risk Calculation app to calculate CVD risk in several populations and explore the effect of individual treatment actions.  

 

Note: The views and opinions expressed on this page are those of the author and may not be accepted by others. While every attempt is made to keep the information up to date, there is always going to be a lag in updating information. The reader is encouraged to read this in conjunction with appropriate ESC Guidelines. The material on this page is for educational purposes and is not for use as a definitive management strategy in the care of patients. Quiz material on the site are only examples and do not guarantee outcomes from formal examinations.

 

References

Prediction of individualized lifetime benefit from cholesterol lowering, blood pressure lowering, antithrombotic therapy and smoking cessation in apparently healthy people, Nicole E M Jaspers et al. European Heart Journal, Volume 41, Issue 11, March 2020

2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk: The Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and European Atherosclerosis Society (EAS), European Heart Journal, Volume 41, Issue 1, 1 January 2020